1. Home
  2. QLGN vs XPON Comparison

QLGN vs XPON Comparison

Compare QLGN & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • XPON
  • Stock Information
  • Founded
  • QLGN 1996
  • XPON 2016
  • Country
  • QLGN United States
  • XPON United States
  • Employees
  • QLGN N/A
  • XPON N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • XPON Electronic Components
  • Sector
  • QLGN Health Care
  • XPON Technology
  • Exchange
  • QLGN Nasdaq
  • XPON Nasdaq
  • Market Cap
  • QLGN 2.4M
  • XPON 1.9M
  • IPO Year
  • QLGN N/A
  • XPON 2022
  • Fundamental
  • Price
  • QLGN $3.32
  • XPON $0.88
  • Analyst Decision
  • QLGN
  • XPON
  • Analyst Count
  • QLGN 0
  • XPON 0
  • Target Price
  • QLGN N/A
  • XPON N/A
  • AVG Volume (30 Days)
  • QLGN 111.5K
  • XPON 61.9K
  • Earning Date
  • QLGN 04-15-2025
  • XPON 03-31-2025
  • Dividend Yield
  • QLGN N/A
  • XPON N/A
  • EPS Growth
  • QLGN N/A
  • XPON N/A
  • EPS
  • QLGN N/A
  • XPON N/A
  • Revenue
  • QLGN N/A
  • XPON $5,624,939.00
  • Revenue This Year
  • QLGN N/A
  • XPON N/A
  • Revenue Next Year
  • QLGN N/A
  • XPON $66.62
  • P/E Ratio
  • QLGN N/A
  • XPON N/A
  • Revenue Growth
  • QLGN N/A
  • XPON N/A
  • 52 Week Low
  • QLGN $2.96
  • XPON $0.86
  • 52 Week High
  • QLGN $29.45
  • XPON $349.00
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 44.88
  • XPON 32.37
  • Support Level
  • QLGN $3.06
  • XPON $0.86
  • Resistance Level
  • QLGN $3.78
  • XPON $0.99
  • Average True Range (ATR)
  • QLGN 0.28
  • XPON 0.08
  • MACD
  • QLGN 0.03
  • XPON 0.01
  • Stochastic Oscillator
  • QLGN 19.80
  • XPON 8.68

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About XPON Expion360 Inc.

Expion360 Inc is focused on the design, assembly, manufacturing and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles ("RV's") and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.

Share on Social Networks: